768 related articles for article (PubMed ID: 24828062)
1. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
2. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs.
Becker CE; O'Neill LA
Semin Immunopathol; 2007 Sep; 29(3):239-48. PubMed ID: 17805544
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
4. NOD-Like Receptors in Infection, Immunity, and Diseases.
Kim YK; Shin JS; Nahm MH
Yonsei Med J; 2016 Jan; 57(1):5-14. PubMed ID: 26632377
[TBL] [Abstract][Full Text] [Related]
5. Collaborative action of Toll-like and NOD-like receptors as modulators of the inflammatory response to pathogenic bacteria.
Oviedo-Boyso J; Bravo-Patiño A; Baizabal-Aguirre VM
Mediators Inflamm; 2014; 2014():432785. PubMed ID: 25525300
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
Wicherska-Pawłowska K; Wróbel T; Rybka J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948194
[TBL] [Abstract][Full Text] [Related]
7. Modulation of toll-like receptors by insulin.
Tilich M; Arora RR
Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors, inflammation, metabolism and obesity.
Fresno M; Alvarez R; Cuesta N
Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
[TBL] [Abstract][Full Text] [Related]
9. Innate sensors of pathogen and stress: linking inflammation to obesity.
Jin C; Flavell RA
J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917
[TBL] [Abstract][Full Text] [Related]
10. The inflammasomes: guardians of the body.
Martinon F; Mayor A; Tschopp J
Annu Rev Immunol; 2009; 27():229-65. PubMed ID: 19302040
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors and NOD-like receptors in rheumatic diseases.
McCormack WJ; Parker AE; O'Neill LA
Arthritis Res Ther; 2009; 11(5):243. PubMed ID: 19835640
[TBL] [Abstract][Full Text] [Related]
12. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases.
McDermott MF; Tschopp J
Trends Mol Med; 2007 Sep; 13(9):381-8. PubMed ID: 17822957
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions between NOD receptors and TLRs: Mechanisms and clinical implications.
Pashenkov MV; Murugina NE; Budikhina AS; Pinegin BV
J Leukoc Biol; 2019 Apr; 105(4):669-680. PubMed ID: 30517768
[TBL] [Abstract][Full Text] [Related]
14. Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs.
Istomin AY; Godzik A
BMC Immunol; 2009 Sep; 10():48. PubMed ID: 19728889
[TBL] [Abstract][Full Text] [Related]
15. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.
Maisonneuve C; Bertholet S; Philpott DJ; De Gregorio E
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12294-9. PubMed ID: 25136133
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of genes involved in TLRs and NLRs signaling pathways of water buffaloes infected with Fasciola gigantica.
Zhang FK; Hou JL; Guo AJ; Tian AL; Sheng ZA; Zheng WB; Huang WY; Elsheikha HM; Zhu XQ
Mol Immunol; 2018 Feb; 94():18-26. PubMed ID: 29241030
[TBL] [Abstract][Full Text] [Related]
17. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.
Mitchell JA; Paul-Clark MJ; Clarke GW; McMaster SK; Cartwright N
J Endocrinol; 2007 Jun; 193(3):323-30. PubMed ID: 17535871
[TBL] [Abstract][Full Text] [Related]
18. NOD-like receptors: role in innate immunity and inflammatory disease.
Chen G; Shaw MH; Kim YG; Nuñez G
Annu Rev Pathol; 2009; 4():365-98. PubMed ID: 18928408
[TBL] [Abstract][Full Text] [Related]
19. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods.
Underhill DM
Immunol Rev; 2007 Oct; 219():75-87. PubMed ID: 17850483
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.
Jialal I; Kaur H; Devaraj S
J Clin Endocrinol Metab; 2014 Jan; 99(1):39-48. PubMed ID: 24187406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
